D Michael Witzeman's Insider Trades & SAST Disclosures
D Michael Witzeman's most recent trade in Chemed Corp. was a trade of 8,796 Stock Option (right to buy with tandem tax withholding) done . Disclosure was reported to the exchange on March 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern D Michael Witzeman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Chemed Corp. | Michael D. Witzeman | VP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Mar 2025 | 8,796 | 34,484 | - | - | Stock Option (right to buy with tandem tax withholding) | |
| Chemed Corp. | Michael D. Witzeman | VP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 445.35 per share. | 10 Mar 2025 | 8,796 | 13,154 (0%) | 0% | 445.4 | 3,917,299 | Capital Stock |
| Chemed Corp. | Michael D. Witzeman | VP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 600.92 per share. | 10 Mar 2025 | 7,494 | 5,660 (0%) | 0% | 600.9 | 4,503,294 | Capital Stock |
| Chemed Corp. | Michael D Witzeman | VP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2024 | 13,395 | 43,280 | - | - | Stock Option (right to buy with tandem tax withholding) | |
| Chemed Corp. | Michael D Witzeman | VP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2024 | 7,948 | 29,885 | - | - | Stock Option (right to buy with tandem tax withholding) | |
| Chemed Corp. | Michael D Witzeman | VP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 471.74 per share. | 31 Jul 2024 | 7,948 | 11,009 (0%) | 0% | 471.7 | 3,749,390 | Capital Stock |
| Chemed Corp. | Michael D Witzeman | VP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 560.99 per share. | 31 Jul 2024 | 7,225 | 3,784 (0%) | 0% | 561.0 | 4,053,153 | Capital Stock |
| Chemed Corp. | Michael D Witzeman | VP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2024 | 1,100 | 37,833 | - | - | Stock Option (right to buy with tandem tax withholding) | |
| Chemed Corp. | Michael D Witzeman | VP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 413.19 per share. | 07 May 2024 | 1,100 | 3,982 (0%) | 0% | 413.2 | 454,509 | Capital Stock |
| Chemed Corp. | Michael D Witzeman | VP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 576.95 per share. | 07 May 2024 | 921 | 3,061 (0%) | 0% | 577.0 | 531,371 | Capital Stock |
| Chemed Corp. | Michael D Witzeman | VP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 643.14 per share. | 20 Mar 2024 | 2,650 | 2,882 (0%) | 0% | 643.1 | 1,704,321 | Capital Stock |
| Chemed Corp. | Michael D Witzeman | VP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 2,600 | 38,933 | - | - | Stock Option (right to buy with tandem tax withholding) | |
| Chemed Corp. | Michael D Witzeman | VP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 413.19 per share. | 20 Mar 2024 | 2,600 | 5,887 (0%) | 0% | 413.2 | 1,074,294 | Capital Stock |
| Chemed Corp. | Michael D Witzeman | VP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 647.44 per share. | 20 Mar 2024 | 355 | 5,532 (0%) | 0% | 647.4 | 229,841 | Capital Stock |
| Chemed Corp. | Michael Witzeman D | VP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 942 | 2,254 | - | - | Performance Share Units | |
| Chemed Corp. | Michael Witzeman D | VP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 278 | 1,312 | - | - | Performance Share Units | |
| Chemed Corp. | Michael Witzeman D | VP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2024 | 278 | 1,590 | - | - | Performance Share Units | |
| Chemed Corp. | Michael Witzeman D | VP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 586.49 per share. | 16 Feb 2024 | 260 | 3,417 (0%) | 0% | 586.5 | 152,487 | Capital Stock |
| Chemed Corp. | D Michael Witzeman | VP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 586.49 per share. | 16 Feb 2024 | 173 | 3,157 (0%) | 0% | 586.5 | 101,463 | Capital Stock |
| Chemed Corp. | Michael D Witzeman | VP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 586.49 per share. | 16 Feb 2024 | 130 | 3,287 (0%) | 0% | 586.5 | 76,244 | Capital Stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2023 | 3,300 | 41,533 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 413.19 per share. | 08 Nov 2023 | 3,300 | 5,669 (0%) | 0% | 413.2 | 1,363,527 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 582.95 per share. | 08 Nov 2023 | 2,685 | 2,984 (0%) | 0% | 583.0 | 1,565,221 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2023 | 12,540 | 44,833 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 666 | 1,868 | - | - | performance stock units | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 515.12 per share. | 17 Feb 2023 | 426 | 2,326 (0%) | 0% | 515.1 | 219,441 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 515.12 per share. | 17 Feb 2023 | 243 | 2,569 (0%) | 0% | 515.1 | 125,174 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 211 | 1,202 | - | - | performance stock units | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Feb 2023 | 211 | 1,413 | - | - | performance stock units | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 515.12 per share. | 17 Feb 2023 | 200 | 2,369 (0%) | 0% | 515.1 | 103,024 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Sale of securities on an exchange or to another person at price $ 498.47 per share. | 10 Nov 2022 | 736 | 1,900 (0%) | 0% | 498.5 | 366,874 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 306.70 per share. | 03 Nov 2022 | 6,900 | 8,086 (0%) | 0% | 306.7 | 2,116,230 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Nov 2022 | 6,900 | 32,293 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 479.27 per share. | 03 Nov 2022 | 5,450 | 2,636 (0%) | 0% | 479.3 | 2,612,022 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Sale of securities on an exchange or to another person at price $ 482.62 per share. | 03 Nov 2022 | 1,300 | 1,186 (0%) | 0% | 482.6 | 627,406 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 8,549 | 39,193 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 646 | 1,624 | - | - | performance stock units | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 459.77 per share. | 18 Feb 2022 | 543 | 2,398 (0%) | 0% | 459.8 | 249,655 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 459.77 per share. | 18 Feb 2022 | 354 | 2,752 (0%) | 0% | 459.8 | 162,759 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 269 | 978 | - | - | performance stock units | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2022 | 269 | 1,247 | - | - | performance stock units | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 459.77 per share. | 18 Feb 2022 | 266 | 2,486 (0%) | 0% | 459.8 | 122,299 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2021 | 8,796 | 30,644 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 491.34 per share. | 19 Feb 2021 | 596 | 3,546 (0%) | 0% | 491.3 | 292,839 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2021 | 556 | 1,516 | - | - | performance stock units | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 491.34 per share. | 19 Feb 2021 | 486 | 4,032 (0%) | 0% | 491.3 | 238,791 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 491.34 per share. | 19 Feb 2021 | 322 | 3,710 (0%) | 0% | 491.3 | 158,211 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 295 | 1,255 | - | - | performance stock units | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Feb 2021 | 295 | 960 | - | - | performance stock units | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Sale of securities on an exchange or to another person at price $ 520.00 per share. | 17 Dec 2020 | 2,500 | 2,950 (0%) | 0% | 520 | 1,300,000 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Nov 2020 | 8,000 | 21,848 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 231.91 per share. | 04 Nov 2020 | 8,000 | 12,001 (0%) | 0% | 231.9 | 1,855,280 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 492.38 per share. | 04 Nov 2020 | 5,551 | 5,450 (0%) | 0% | 492.4 | 2,733,201 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Sale of securities on an exchange or to another person at price $ 514.73 per share. | 04 Nov 2020 | 1,000 | 11,001 (0%) | 0% | 514.7 | 514,730 | capital stock |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2020 | 7,948 | 29,848 | - | - | stock option(right to buy with tandem tax withholding) | |
| Chemed Corp. | Michael D Witzeman | vice president and controller | Sale of securities on an exchange or to another person at price $ 500.00 per share. | 03 Aug 2020 | 2,000 | 4,001 (0%) | 0% | 500 | 1,000,000 | capital stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges